DELFI / Tomas Vinickas
Only scientists who make extraordinary contributions to life sciences are accepted into the prestigious organization. 84 members of EMBO have been awarded the Nobel Prize since the establishment of the organization in 1964.
Professor Šikšnys was elected as an associate member of EMBO on May 23, alongside seven other scientists from among others, Harvard Medical School, University of Beijing, Genome Institute of Singapore and other renowned scientific institutions.
Professor Šikšnys is developing the CRISPR system, which enables the precise editing of particular DNA sequences in order to fix the flaws of improper genes and which many believe may lead to the award of a Nobel prize.
Earlier this year Professor Šikšnys shared a prestigious award of the Warren Alpert Foundation with other four scientists for their remarkable contributions to the understanding of the CRISPR bacterial defence system and how it can be adapted for genome editing.
Vilnius University Rector Profesoor Artūras Žukauskas said that such recognition is significant for Lithuania.
“The selection of professor Šikšnys as an Associate Member of EMBO is another sign of recognition for VU scientists for their international achievements,” he said.
In total eight scientists from China, Japan, Singapore, United States and Lithuania have been recently elected as Associated Members of EMBO.
On March 31 morning, Minister of National Defence Dovilė Šakalienė announced that an M88 armoured…
I admit it: I’m not that type of person who follows domestic and international politics…
While Prime Minister Gintautas Paluckas does not take issue with the statements made by the…
Lithuanian economists are surprised to see our country's economic growth: the Estonian economy has been…
"The fate of Nemuno Aušra (Dawn of Nemunas) in the coalition has been decided; they…
Airvolve, a Lithuanian dual-purpose aeronautics company, has successfully completed its first round of testing and…